Literature DB >> 23685884

Haplotype TGTG from SNP 45T/G and 276G/T of the adiponectin gene contributes to risk of polycystic ovary syndrome.

S Radavelli-Bagatini1, I O de Oliveira, R B Ramos, B R Santos, M S Wagner, S B Lecke, D P Gigante, B L Horta, P M Spritzer.   

Abstract

BACKGROUND: Haplotypes of adiponectin gene single nucleotide polymorphisms (SNP) might be related to metabolic disorders. AIM: To assess whether the prevalence of SNP 45T/G and 276G/T of the adiponectin gene and their haplotypes differ between polycystic ovary syndrome (PCOS) and non-hirsute cycling controls and to investigate the relationship between these haplotypes and risk factors for cardiovascular disease. SUBJECTS AND METHODS: In this case-control study, 80 women with PCOS and 1500 non-hirsute controls with regular cycles underwent clinical and laboratory measurements. Genotype distribution was analyzed by conventional PCR-restriction fragment length polymorphism.
RESULTS: Compared to controls, PCOS women had greater body mass index (BMI) (31.0±7.9 kg/m² vs 23.4±4.6 kg/m²; p<0.001), waist circumference (92.2±18.8 cm vs 74.5±10.2 cm; p<0.001), and systolic and diastolic blood pressure (124.6±19.9 vs 111.5±13.0 mmHg and 79.2±12.5 vs 71.8±10.6 mmHg; p<0.025), as well as a worse lipid profile (p<0.007), even after adjustment for age and BMI. Genotype distribution was similar in PCOS and controls (45T/G: p=0.399; 276G/T: p=0.135). Six haplotypes were inferred and their frequencies differed significantly between the groups (p=0.001). The TGTG haplotype was more frequent in PCOS than controls (41.3 vs 18.9%). In PCOS, the GG genotype for SNP 276 (p=0.031) and the TGTG haplotype (p=0.023) were associated with higher systolic blood pressure vs other genotypes and haplotypes. Body composition, glucose, insulin, and lipid profile were similar across genotypes and haplotypes in both groups.
CONCLUSIONS: Haplotype TGTG from adiponectin gene variants 45T/G and 276G/T is related to susceptibility to PCOS, and might be associated with increased blood pressure in PCOS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23685884     DOI: 10.3275/8966

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  53 in total

1.  Variation in metabolic and cardiovascular risk in women with different polycystic ovary syndrome phenotypes.

Authors:  Denusa Wiltgen; Poli Mara Spritzer
Journal:  Fertil Steril       Date:  2010-03-24       Impact factor: 7.329

2.  The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians.

Authors:  Vitolds Mackevics; Iris M Heid; Stefanie A Wagner; Paula Cip; Hildegard Doppelmayr; Aivars Lejnieks; Henning Gohlke; Günther Ladurner; Thomas Illig; Bernhard Iglseder; Florian Kronenberg; Bernhard Paulweber
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

5.  Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.

Authors:  Mariana K Toscani; Fernanda M Mario; Simone Radavelli-Bagatini; Poli Mara Spritzer
Journal:  Nutr Res       Date:  2011-02       Impact factor: 3.315

6.  Association of serum adiponectin concentration to lipid and glucose metabolism in healthy humans.

Authors:  M K Heliövaara; T E Strandberg; S-L Karonen; P Ebeling
Journal:  Horm Metab Res       Date:  2006-05       Impact factor: 2.936

Review 7.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

8.  [Early determinants of random blood glucose among adults of the 1982 birth cohort, Pelotas, Southern Brazil].

Authors:  Bernardo L Horta; Denise P Gigante; Cesar G Victora; Fernando C Barros; Isabel Oliveira; Vera Silveira
Journal:  Rev Saude Publica       Date:  2008-12       Impact factor: 2.106

9.  Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women.

Authors:  Ning Zhang; Yu-Hua Shi; Cui-Fang Hao; Harvest F Gu; Yuan Li; Yue-Ran Zhao; Lai-Cheng Wang; Zi-Jiang Chen
Journal:  Eur J Endocrinol       Date:  2008-02       Impact factor: 6.664

10.  Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.

Authors:  Ren-Min Ni; Yaqin Mo; Xiaoli Chen; Junmin Zhong; Wen Liu; Dongzi Yang
Journal:  Eur J Endocrinol       Date:  2009-06-19       Impact factor: 6.664

View more
  6 in total

Review 1.  Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Ramon Bossardi Ramos; Vitor Costa Fabris; Letícia de Almeida Brondani; Poli Mara Spritzer
Journal:  Endocrine       Date:  2015-02-13       Impact factor: 3.633

2.  Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids.

Authors:  Dessie Salilew-Wondim; Qi Wang; Dawit Tesfaye; Karl Schellander; Michael Hoelker; Md Munir Hossain; Benjamin K Tsang
Journal:  J Ovarian Res       Date:  2015-04-13       Impact factor: 4.234

3.  Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis.

Authors:  Zhengling Liu; Zengyan Wang; Changhong Hao; Yonghui Tian; Jingjing Fu
Journal:  Reprod Biol Endocrinol       Date:  2018-12-03       Impact factor: 5.211

4.  Metabolic profile of women with PCOS in Brazil: a systematic review and meta-analysis.

Authors:  Ramon Bossardi Ramos; Lucas Bandeira Marchesan; Poli Mara Spritzer; Monica de Oliveira; Enrico Carmina
Journal:  Diabetol Metab Syndr       Date:  2021-02-16       Impact factor: 3.320

5.  Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review.

Authors:  Lucas Bandeira Marchesan; Ramon Bossardi Ramos; Poli Mara Spritzer
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-19       Impact factor: 5.555

6.  Molecular Targets and Associated Signaling Pathways of Jingshu Granules in Ovarian Cysts Based on Systemic Pharmacological Analysis.

Authors:  Jili Xu; Yincong Xu; Ye Zhu; Zhihui Li; Xiaoping Wang
Journal:  Biomed Res Int       Date:  2021-01-21       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.